Compared with AhR+/+ transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, AhR−/− TRAMP mice showed a higher incidence of prostate cancer accompanied by an increase in VEGF [60]. This evidence concerns the gene AHR and Familial prostate cancer.